Forward Industries, Inc. announced that as of July 1, 2026, it has 73,846,883 common shares outstanding after repurchasing 13,316,224 shares. The company also has outstanding options to purchase 1,811,666 shares, restricted and performance stock units convertible into 2,107,732 shares, and warrants for 25,759,600 shares. These disclosures comply with Rule 2.12 of the Irish Takeover Rules, ensuring transparency about the company's share structure and potential dilution. This information is important for investors monitoring ownership and takeover-related activities.
Sanofi has released its Q2 2026 aide-mémoire document on its investor website to assist financial modeling for the upcoming quarterly results. This memo includes details on non-comparable items, currency impacts, and share count. The full Q2 2026 ear...
Abivax, a clinical-stage biotech company, has temporarily suspended trading of its ordinary shares on Euronext Paris starting July 1, 2026, at 9:00 CEST. This suspension is at Abivax's request to facilitate the confirmation of allocations and final t...
The global human fibrinogen concentrate market is projected to grow from approximately $0.95 billion in 2025 to $2.78 billion by 2035, at a compound annual growth rate (CAGR) of 11.3%. This growth is fueled by increasing cases of bleeding disorders, ...
Disney and Blue Star Families held a special screening of Toy Story 5 at Camp Pendleton for nearly 500 military family members, featuring appearances by characters and giveaways. Disney CEO Josh D’Amaro surprised attendees with Disneyland tickets to ...
New York Life Investment Management (NYLIM) has partnered with Centrifuge to launch its first tokenized fund, the NYLIM Anemoy U.S. High Yield Corporate Bond Segregated Portfolio (ticker HYB). This fund brings NYLIM's high-yield corporate bond strate...
